Emelie Foord is a Senior Validation Lead in Assay Development at Devyser, where they are currently contributing to the company's growth. With a PhD in tumor immunology from Karolinska Institutet, defended in 2021, Emelie has a rich background in clinical research and laboratory sciences, with a focus on immune responses in cancer treatments. Their previous roles include Director of Immunology Research at Circio Holding ASA and Scientist at XNK Therapeutics, where they worked on autologous NK cells. Emelie's academic journey includes multiple degrees in laboratory sciences and extensive publication in tumor immunology and related fields.
This person is not in the org chart
This person is not in any teams
This person is not in any offices